Co-prescription of medication for bipolar disorder and diabetes mellitus: a nationwide population-based study with focus on gender differences
Open accessThe DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Studies have shown a correlation between bipolar disorder and diabetes mellitus. It is unclear if this correlation is a part of common pathophysiological pathways, or if medication for bipolar disorder has negative effects on blood sugar regulation. METHODS: The Norwegian prescription database was analyzed. Prescriptions for lithium, lamotrigine, carbamazepine and valproate were used as proxies for bipolar disorder. Prescriptions for insulin and oral anti-diabetic agents were used as proxies for diabetes mellitus. We explored the association between medication for bipolar disorder and diabetes medication by logistic regression RESULTS: We found a strong association between concomitant use of medication to treat diabetes mellitus and mood stabilizers for the treatment of bipolar disorder. Females had a 30% higher risk compared to men of being treated for both disorders. Persons using oral anti-diabetic agents had higher odds of receiving valproate than either lithium or lamotrigine. Use of insulin as monotherapy seemed to have lower odds than oral anti-diabetic agents of co-prescription of mood stabilizers, compared to the general population. CONCLUSIONS: This study showed a strong association between the use of mood stabilizers and anti-diabetic agents. The association was stronger among women than men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Divalproex has been associated with motor side effects645 and metabolic effects (weight gain and diabetes mellitus).647”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951 · cited 1×
“The European Psychiatric Association emphasizes the need to focus on diabetic comorbidity in patients with severe mental illness [5].”
BackgroundPrevalence and Correlates of Diabetes in National Schizophrenia Samples
Dixon, L., Weiden, P., Delahanty, J., Goldberg, R., Postrado, L., Lucksted, A., & Lehman, A. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033504 · Cited by 569 · cited 1×
“Mood stabilizers might be used by patients diagnosed with other psychiatric diagnoses, such as schizophrenia, and this presents a possible confounder, as the prevalence of diabetes is increased in patients with schizophrenia [25].”
BackgroundLithium Inhibits Glycogen Synthase Kinase-3 by Competition for Magnesium
Ryves, W. J., & Harwood, A. J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4169 · Cited by 493 · cited 1×
“Valproate and lithium both inhibit glycogen synthase kinase 3b [18,19], as does insulin.”
BackgroundThe Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3
Chen, G., Huang, L., Jiang, Y., & Manji, H. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0721327.x · Cited by 438 · cited 1×
“Valproate and lithium both inhibit glycogen synthase kinase 3b [18,19], as does insulin.”
BackgroundGallego, J. A., Bonetti, J., Zhang, J., Kane, J. M., & Correll, C. U. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.03.018 · Cited by 332
Association of high-sensitivity C-reactive protein with de novo major depression
Pasco, J. A., Nicholson, G. C., Williams, L. J., Jacka, F. N., Henry, M. J., Kotowicz, M. A., Schneider, H. G., Leonard, B. E., & Berk, M. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.076430 · Cited by 321 · cited 1×
“The finding of the high diabetes prevalence in patients with bipolar disorder could indicate that those with this disorder are at higher risk for diabetes by virtue of a shared pathophysiology common to both disorders, such as inflammation [20,21].”
BackgroundSelf-citationElevated Frequency of Diabetes Mellitus in Hospitalized Manic-Depressive Patients
Cassidy, F., Ahearn, E., & Carroll, J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1417 · Cited by 299 · cited 2×
“The comorbidity between diabetes mellitus and bipolar disorder has been explored in several studies, with the estimated prevalence varying from about two to five times higher than in the general population [1-4].”
BackgroundRegenold, W. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00456-6 · Cited by 293 · cited 2×
“The comorbidity between diabetes mellitus and bipolar disorder has been explored in several studies, with the estimated prevalence varying from about two to five times higher than in the general population [1-4].”
BackgroundSmith, M., Hopkins, D., Peveler, R. C., Holt, R. I. G., Woodward, M., & Ismail, K. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.037184 · Cited by 275 · cited 1×
“Of probable greater importance is the ability of antipsychotics to induce diabetes [28].”
BackgroundMedical Comorbidity in Women and Men With Bipolar Disorders: A Population-Based Controlled Study
Carney, C. P., & Jones, L. E. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000237316.09601.88 · Cited by 229
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationCharles, E. F., Lambert, C. G., & Kerner, B. (2016) · International Journal of Bipolar Disorders · doi:10.1186/s40345-016-0054-4 · Cited by 70
“60 0 (1 .4 29 –1 .7 92 ) fo r m en 0– 85 + 20 58 ,4 08 96 ,1 03 w ith D M 63 41 w ith B D C ru m p et a l. 20 13 Co m or bi di tie s an d m or ta lit y in bi po la r d is or de r: a Sw ed is h na tio na l c oh or t st ud y N at io na l c oh or t st ud y C ro ss -s ec tio na l BD IC D -1 0 co de F…”
Using Lithium in Older Age Bipolar Disorder: Special Considerations
Soh, J. F., Klil‐Drori, S., & Rej, S. (2019) · Drugs & Aging · doi:10.1007/s40266-018-0628-1 · Cited by 62
Rej, S., Yu, C., Shulman, K. I., Herrmann, N., Fischer, H. D., Fung, K., & Gruneir, A. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.07.001 · Cited by 52
Common biological mechanisms between bipolar disorder and type 2 diabetes: Focus on inflammation
Sharma, A. N., Bauer, I. E., Sanches, M., Galvez, J. F., Zunta‐Soares, G. B., Quevedo, J., Kapczinski, F. P., & Soares, J. C. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.06.005 · Cited by 38
“A recent study suggested a strong inclination of prescribers toward co-prescription of antidiabetics and mood stabilizers (Svendal et al., 2012).”
Background
Metadata
- Authors
- Svendal, G., Fasmer, O. B., Engeland, A., Berk, M., & Lund, A.
- Affiliations
- Haukeland University Hospital (NO)
- Norwegian Institute of Public Health (NO)
- The Royal Melbourne Hospital (AU)
- Corresponding author
- Svendal, Gjertrud
- Venue
- BMC Medicine
- Published
- 2012-11-27
- Volume
- 10
- Issue
- 1
- Pages
- 148-148
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC3534576
- OpenAlex
- W2092331578
- Cited by
- 17
- References
- 31
- Citations by year
- 2025: 1 · 2022: 1 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 1 · 2014: 4
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Universitetet i Bergen
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- bipolar disorder, diabetes mellitus, co-prescription, mood stabilizers, lithium, lamotrigine, carbamazepine, valproic acid, insulin, oral antidiabetic drugs, gender differences, polypharmacy, blood sugar regulation
- MeSH terms
- Adult, Aged, Bipolar Disorder, Cross-Sectional Studies, Diabetes Mellitus, Drug Therapy, Combination, Female, Humans, Hypoglycemic Agents, Male, Middle Aged, Sex Factors, Antimanic Agents, Diabetes Complications, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Co-prescription of medication for bipolar disorder and diabetes mellitus: a nationwide population-based study with focus on gender differences. https://app.cochat.ai/papers/10.1186/1741-7015-10-148
- The paper
- Svendal, G., Fasmer, O. B., Engeland, A., Berk, M., & Lund, A. (2012). Co-prescription of medication for bipolar disorder and diabetes mellitus: a nationwide population-based study with focus on gender differences. BMC Medicine. https://doi.org/10.1186/1741-7015-10-148
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.